Daniel Thomas

A new partnership proves AI is only as good as its data, achieving a 10% lift in predictive models and a 19.5% drop in wasted marketing spend.

As traditional lenders become more restrictive, alternative finance firm Bizcap is boosting its low-doc loan cap, offering a faster path to capital for UK SMEs.

Oregon-based SELCO Credit Union is overhauling its employee knowledge systems with eGain AI, aiming to boost efficiency, compliance, and member service.

With a new finance head, the non-profit plans to launch a breakthrough vitamin A product in Africa, blending philanthropy with commercial strategy.

A new partnership between Chef Robotics and Packline brings AI-powered assembly and packaging to food factories, promising massive efficiency gains.

The home goods giant partners with Google on an open standard, enabling direct checkout from AI search and heralding a new era of agentic commerce.

As Polk County's population soars, a new emergency room aims to bring critical care closer to home, sparking a new chapter in the region's healthcare race.

Unrivaled's renewed partnership with Mount Sinai isn't just a deal; it's a statement on player health, setting a new benchmark for women's pro sports.

The supply chain tech leader appoints a seasoned marketing exec from Drift and Salesforce to accelerate its next growth phase and amplify its AI strategy.

A joint venture of Elliott and Morning Calm has acquired City Office REIT, a bold move signaling a contrarian belief in the office market's recovery.

Amid a massive wealth migration to the Sunshine State, Glenmede appoints Joe Coconate to lead its charge in the highly competitive UHNW market.

A new report reveals 10 proven ways to fix the critical mental health gap for trafficking survivors, as 75% call it their most urgent need.

With a key drug in late-stage trials and a bolstered team, Palvella Therapeutics aims to deliver the first FDA-approved therapies for rare skin diseases.

Raleigh-based Attindas Hygiene Partners acquires 53-year-old Italian firm SILC, a strategic move to capture a larger share of Europe's booming hygiene market.

Ocugen heads to a top investor conference with a bold plan for its gene-agnostic therapy, aiming to treat blindness and secure its future in a crowded market.

Belgian biotech MRM Health gets the green light for a Phase 2b trial of MH002, a novel 'living drug' aimed at revolutionizing ulcerative colitis care.

As Valneva meets investors, all eyes are on its pivotal Lyme disease vaccine data, a potential game-changer for public health and the company's future.

New research reveals a stark disconnect between clinical views and patient reality in atopic dermatitis, with millions suffering severe, overlooked impacts.

After two decades, Dr. Andrew Weil and daughter Diana unveil a modern, simplified Anti-Inflammatory Food Pyramid, launching a new digital health era.

A new survey shows no firm recovers from cyberattacks in a day, with downtime lasting weeks. Yet, executive focus on resilience may be dangerously waning.